These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24256655)

  • 81. Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy.
    Paradis E; Cao Y; Lawrence TS; Tsien C; Feng M; Vineberg K; Balter JM
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1154-61. PubMed ID: 26581151
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
    Kozak MM; Koenig JL; von Eyben R; Kidd EA
    Pract Radiat Oncol; 2019 Mar; 9(2):e164-e171. PubMed ID: 30395974
    [TBL] [Abstract][Full Text] [Related]  

  • 83. High-grade osteosarcoma of the mandible: a rare tumor successfully treated with surgery and image-guided volumetric modulated arc therapy.
    Ahmad I; Bhatt CP; Bashir I; Rathour S
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30061147
    [No Abstract]   [Full Text] [Related]  

  • 84. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
    Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Re: Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life after Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.
    Taneja SS
    J Urol; 2017 Jan; 197(1):149-152. PubMed ID: 27979505
    [No Abstract]   [Full Text] [Related]  

  • 88. Status and innovations in pre-treatment CT imaging for proton therapy.
    Wohlfahrt P; Richter C
    Br J Radiol; 2020 Mar; 93(1107):20190590. PubMed ID: 31642709
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A systematic review of volumetric image guidance in proton therapy.
    Herrick M; Penfold S; Santos A; Hickson K
    Phys Eng Sci Med; 2023 Sep; 46(3):963-975. PubMed ID: 37382744
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Proton therapy verification with PET imaging.
    Zhu X; El Fakhri G
    Theranostics; 2013 Sep; 3(10):731-40. PubMed ID: 24312147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Implementation of New Biology-Based Radiation Therapy Technology: When Is It Ready So "Perfect Makes Practice?".
    Coleman CN; Ahmed MM
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):934-937. PubMed ID: 31748143
    [No Abstract]   [Full Text] [Related]  

  • 92. NCRP 54th Annual Meeting, Radiation Protection Responsibility in Medicine: Nuclear Medicine and Radiation Oncology Q&A (Questions for Frederic H. Fahey, Melissa C. Martin, George sgouros, and Bruce Thomadsen).
    Held K
    Health Phys; 2019 Feb; 116(2):205-206. PubMed ID: 30585964
    [No Abstract]   [Full Text] [Related]  

  • 93. When should proton radiation therapy be used to treat brain tumors?
    Loeffler J
    CNS Oncol; 2012 Nov; 1(2):123-5. PubMed ID: 25057861
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Promises and pitfalls of new technology in radiotherapy.
    Guedea F
    Clin Transl Oncol; 2012 Sep; 14(9):631-3. PubMed ID: 22855187
    [No Abstract]   [Full Text] [Related]  

  • 95. Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy.
    Gao D; Sun X; Gao L; Liu Z
    Curr Drug Targets; 2015; 16(6):634-44. PubMed ID: 26028045
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Preserve sexual function after high-dose image-guided proton therapy for prostate cancer].
    Thomas E; Hölscher T; Krause M
    Strahlenther Onkol; 2020 Mar; 196(3):293-295. PubMed ID: 31960088
    [No Abstract]   [Full Text] [Related]  

  • 97. Molecular Positron Emission Tomography in Cardiac Ischemia/Reperfusion.
    Yap ML; Peter K
    Circ Res; 2019 Mar; 124(6):827-829. PubMed ID: 30870125
    [No Abstract]   [Full Text] [Related]  

  • 98. Evolving Use of Molecular Imaging in Research and in Practice.
    Tawakol A; Unizony S; Osborne MT; Massarotti E; Giles JT
    Arthritis Rheumatol; 2019 Aug; 71(8):1207-1210. PubMed ID: 30835948
    [No Abstract]   [Full Text] [Related]  

  • 99. State-of-the-Art of Radiometal-based Bioconjugates for Molecular Imaging and Radiotherapy.
    Ma MT; Lewis JS
    Bioconjug Chem; 2021 Jul; 32(7):1175-1176. PubMed ID: 34284590
    [No Abstract]   [Full Text] [Related]  

  • 100. [Study of dose-volume delivery guided proton therapy].
    Nishio T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2013 Nov; 69(11):1297-305. PubMed ID: 24256655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.